Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1807 1
1814 1
1850 1
1853 2
1856 1
1859 1
1861 1
1864 1
1866 2
1870 1
1871 3
1893 1
1896 3
1897 1
1920 1
1924 1
1926 1
1927 1
1932 2
1933 2
1935 2
1936 1
1938 3
1939 3
1941 1
1943 1
1944 1
1946 9
1947 4
1948 3
1949 7
1950 8
1951 7
1952 7
1953 2
1954 5
1955 8
1956 6
1957 6
1958 5
1959 10
1960 6
1961 6
1962 7
1963 5
1964 10
1965 9
1966 12
1967 12
1968 25
1969 18
1970 15
1971 16
1972 19
1973 4
1974 5
1975 10
1976 6
1977 6
1978 10
1979 18
1980 13
1981 10
1982 13
1983 19
1984 14
1985 10
1986 24
1987 31
1988 27
1989 32
1990 28
1991 26
1992 29
1993 31
1994 17
1995 30
1996 31
1997 53
1998 40
1999 34
2000 41
2001 29
2002 53
2003 48
2004 43
2005 51
2006 74
2007 58
2008 64
2009 82
2010 75
2011 84
2012 87
2013 105
2014 125
2015 130
2016 116
2017 115
2018 110
2019 141
2020 160
2021 170
2022 157
2023 152
2024 147
2025 175
2026 61

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,149 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.
Oh DY, He AR, Bouattour M, Okusaka T, Qin S, Chen LT, Kitano M, Lee CK, Kim JW, Chen MH, Suksombooncharoen T, Ikeda M, Lee MA, Chen JS, Potemski P, Burris HA 3rd, Ostwal V, Tanasanvimon S, Morizane C, Zaucha RE, McNamara MG, Avallone A, Cundom JE, Breder V, Tan B, Shimizu S, Tougeron D, Evesque L, Petrova M, Zhen DB, Gillmore R, Gupta VG, Dayyani F, Park JO, Buchschacher GL Jr, Rey F, Kim H, Wang J, Morgan C, Rokutanda N, Żotkiewicz M, Vogel A, Valle JW. Oh DY, et al. Among authors: morgan c. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):694-704. doi: 10.1016/S2468-1253(24)00095-5. Epub 2024 May 29. Lancet Gastroenterol Hepatol. 2024. PMID: 38823398 Clinical Trial.
CMC Regulatory Considerations for Antibody-Drug Conjugates.
Bechtold-Peters K, Ruggiero A, Vriezen N, Ihle N, Klein A, Morgan C, Schweizer D, Liu D, Jacobson F, Buecheler J, Panek M, Duggan N, Malyala P, Dupraz P, Desai P, Niu S, Feng Y, Wang X. Bechtold-Peters K, et al. Among authors: morgan c. J Pharm Sci. 2023 Dec;112(12):2965-2980. doi: 10.1016/j.xphs.2023.09.007. Epub 2023 Sep 21. J Pharm Sci. 2023. PMID: 37741455 Review.
Endometriosis: cannabidiol therapy for symptom relief.
Whitaker LHR, Page C, Morgan C, Horne AW, Saunders PTK. Whitaker LHR, et al. Among authors: morgan c. Trends Pharmacol Sci. 2024 Dec;45(12):1150-1161. doi: 10.1016/j.tips.2024.10.014. Epub 2024 Nov 14. Trends Pharmacol Sci. 2024. PMID: 39547915 Free article. Review.
The Reply.
Moore HJ, Wu WC, Patel SS, Lam PH, Morgan CJ, Faselis C, Zhang S, Sheriff HM, Zeng-Treitler Q, Fonarow GC, Ahmed A. Moore HJ, et al. Among authors: morgan cj. Am J Med. 2025 Nov;138(11):e241-e242. doi: 10.1016/j.amjmed.2025.06.023. Am J Med. 2025. PMID: 41167918 No abstract available.
Randomized Comparison Trial of Rehabilitation Very Early for Infants with Congenital Hemiplegia.
Boyd RN, Greaves S, Ziviani J, Novak I, Badawi N, Pannek K, Elliott C, Wallen M, Morgan C, Valentine J, Findlay L, Guzzetta A, Whittingham K, Ware RS, Fiori S, Maitre NL, Heathcock J, Scott K, Eliasson AC, Sakzewski L. Boyd RN, et al. Among authors: morgan c. J Pediatr. 2025 Feb;277:114381. doi: 10.1016/j.jpeds.2024.114381. Epub 2024 Oct 29. J Pediatr. 2025. PMID: 39477009 Free article. Clinical Trial.
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial.
Corboy JR, Fox RJ, Kister I, Cutter GR, Morgan CJ, Seale R, Engebretson E, Gustafson T, Miller AE; DISCOMS investigators. Corboy JR, et al. Among authors: morgan cj. Lancet Neurol. 2023 Jul;22(7):568-577. doi: 10.1016/S1474-4422(23)00154-0. Lancet Neurol. 2023. PMID: 37353277 Clinical Trial.
Protocol for a randomized controlled trial to evaluate a year-long (NICU-to-home) evidence-based, high dose physical therapy intervention in infants at risk of neuromotor delay.
Deng W, Anastasopoulos S, deRegnier RA, Pouppirt N, Barlow AK, Patrick C, O'Brien MK, Babula S, Sukal-Moulton T, Peyton C, Morgan C, Rogers JA, Lieber RL, Jayaraman A. Deng W, et al. Among authors: morgan c. PLoS One. 2023 Sep 19;18(9):e0291408. doi: 10.1371/journal.pone.0291408. eCollection 2023. PLoS One. 2023. PMID: 37725613 Free PMC article.
Rethinking Paediatric Cardiology Training in Canada.
Gritti MN, Morgan CT. Gritti MN, et al. Among authors: morgan ct. CJC Pediatr Congenit Heart Dis. 2023 Nov 27;3(1):43-46. doi: 10.1016/j.cjcpc.2023.11.002. eCollection 2024 Feb. CJC Pediatr Congenit Heart Dis. 2023. PMID: 38544882 Free PMC article. No abstract available.
3,149 results